Bruderman Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Bruderman Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-163	Closed	-$3K	–	334
2017 Q2	$3K	Buy	+163	New	+$2.35K	﹤0.01%	344
2017 Q1	–	Sell	-160	Closed	-$3K	–	337
2016 Q4	$3K	Sell	160 -315	-66%	-$5.53K	﹤0.01%	345
2016 Q3	$9K	Buy	475 +5	+1%	+$98	﹤0.01%	339
2016 Q2	$9K	Hold	470	–	–	﹤0.01%	320
2016 Q1	$10K	Sell	470 -209	-31%	-$4.12K	﹤0.01%	322
2015 Q4	$14K	Buy	679 +2	+0.3%	+$38	0.01%	315
2015 Q3	$12K	Buy	677 +2	+0.3%	+$37	﹤0.01%	327
2015 Q2	$13K	Sell	675 -423	-39%	-$7.84K	0.01%	333
2015 Q1	$21K	Buy	+1,098	New	+$20.3K	0.01%	290

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bruderman Asset Management's VIVO Position: Q3 2017 in Review

Bruderman Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2017, closing a stake of 163 shares — an estimated $3K sold.

Bruderman Asset Management first reported a position in VIVO in Q1 2015 and held it in 9 quarters. The position peaked at $21K in Q1 2015. 172 funds tracked by Wall St. Rank hold VIVO as of Q3 2017.

Bruderman Asset Management reported no remaining Meridian Bioscience Inc position as of Q3 2017 after selling out during the quarter.
Bruderman Asset Management sold 163 Meridian Bioscience Inc shares in Q3 2017, an estimated $3K.
Bruderman Asset Management first reported a position in Meridian Bioscience Inc in Q1 2015 and held it in 9 quarters.
Bruderman Asset Management's Meridian Bioscience Inc position peaked at $21K in Q1 2015.
172 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2017.

Based on Bruderman Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.